Why Young Women Have More Adverse Outcomes After a Heart Attack Than Young Men

Health & Lifestyle
275

Listen to article (english)

Translate to Spanish or other 102 languages!

Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. Image for illustration purposes
Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. Image for illustration purposes

Medical News Today

- Advertisement -
  • Researchers say younger women tend to have worse outcomes after having a heart attack than younger men.
  • They add that younger women are also more likely to return to the hospital in the year following a heart attack.
  • Experts say among other factors younger women tend to wait longer to seek treatment after experiencing heart ailments.

Younger women who have had a heart attack have more adverse outcomes and are more likely to return to the hospital in the year following their heart attack than men of a similar age. 

Follow the link below to read the full story on Medical News Today:

https://www.medicalnewstoday.com/articles/young-women-more-likely-to-return-to-the-hospital-in-year-following-heart-attack-emb?utm_source=Sailthru%20Email&utm_medium=Email&utm_campaign=MNT%20Daily%20News&utm_content=2023-05-02&apid=&rvid=4ba4ec80177cae00eabc43b8bc6648d598c4a356d104663735777e0a0f8b5c9f

- Advertisement -

Information Source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
A Safer Blood Thinner? 
Next article
Preventing Tick Bites & Lyme Disease

More Articles

FDA Authorizes First Wearable Device that Continuously Monitors Both Ketone Levels and Blood Sugar

The U.S. Food and Drug Administration today authorized the Libre Duo 10 Day Continuous Dual Glucose Ketone Monitoring System for people aged 2 years and older living with diabetes.

Golden Years, Restless Nights: How Aging Transforms Your Sleep Cycles

If you have trouble falling asleep or staying asleep, your age could be playing a role.

FDA Approves First in Class Targeted Therapy for Metastatic Pancreatic Cancer

The U.S. Food and Drug Administration approved Rasonque (daraxonrasib), a RAS inhibitor for the most common form of pancreatic cancer—delivering a new treatment option to patients with advanced pancreatic cancer months ahead of schedule. 

STHS Behavioral’s Webinar on Suicide Prevention Awareness, Sept. 3rd

More than 49,000 people died by suicide in the United States in 2023, according to the Centers for Disease Control and Prevention (CDC), making it one of the leading causes of death among adolescents and adults.
- Advertisement -